AAAAAA
Results:
1-16
|
Results: 16
Authors:
Edwards, J
Krishna, NS
Mukherjee, R
Watters, AD
Underwood, MA
Bartlett, JMS
Citation: J. Edwards et al., Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer, BJU INT, 88(6), 2001, pp. 633-637
Authors:
Crilly, A
Bartlett, JMS
White, A
Stirling, D
Capell, H
Madhok, R
Citation: A. Crilly et al., Investigation of novel polymorphisms within the 3 ' region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis, CYTOKINE, 13(2), 2001, pp. 109-112
Authors:
Watters, AD
Stacey, MW
Going, JJ
Grigor, KM
Cooke, TG
Sim, E
Bartlett, JMS
Citation: Ad. Watters et al., Genetic aberrations of NAT2 and chromosome 8: Their association with progression in transitional cell carcinoma of the urinary bladder, UROL INTERN, 67(3), 2001, pp. 235-239
Authors:
Bartlett, JMS
Going, JJ
Mallon, EA
Watters, AD
Reeves, JR
Stanton, P
Richmond, J
Donald, B
Ferrier, R
Cooke, TG
Citation: Jms. Bartlett et al., Evaluating HER2 amplification and overexpression in breast cancer, J PATHOLOGY, 195(4), 2001, pp. 422-428
Authors:
Watters, AD
Ballantyne, SA
Going, JJ
Grigor, KM
Bartlett, JMS
Citation: Ad. Watters et al., Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder, BJU INT, 85(1), 2000, pp. 42-47
Authors:
Langdon, SP
Edwards, J
Bartlett, JMS
Citation: Sp. Langdon et al., Ovarian cancer models - Technical review, METH MOL M, 39, 2000, pp. 145-153
Authors:
Watters, AD
Bartlett, JMS
Citation: Ad. Watters et Jms. Bartlett, Quantitation of FISH signals in archival tumors, METH MOL M, 39, 2000, pp. 253-260
Authors:
Bartlett, JMS
Citation: Jms. Bartlett, mRNA analyses - A technical overview, METH MOL M, 39, 2000, pp. 399-409
Authors:
Bartlett, JMS
Citation: Jms. Bartlett, RNase protection assay analysis of mRNA for TGF beta(1-3) in ovarian tumors, METH MOL M, 39, 2000, pp. 431-437
Authors:
Reeves, JR
Bartlett, JMS
Citation: Jr. Reeves et Jms. Bartlett, Measurement of protein expression - A technical overview, METH MOL M, 39, 2000, pp. 471-483
Authors:
Edwards, J
Bartlett, JMS
Citation: J. Edwards et Jms. Bartlett, Phosphotyrosine kinase assays as a prescreen for inhibitors of EGFr, METH MOL M, 39, 2000, pp. 577-581
Authors:
Edwards, J
Bartlett, JMS
Citation: J. Edwards et Jms. Bartlett, Direct kinase assay screening for inhibitors of MAP kinase, METH MOL M, 39, 2000, pp. 583-588
Authors:
Bartlett, JMS
Adie, L
Watters, AD
Going, JJ
Grigor, KM
Citation: Jms. Bartlett et al., Chromosomal aberrations in transitional cell carcinoma that are predictiveof disease outcome are independent of polyploidy, BJU INT, 84(7), 1999, pp. 775-779
Authors:
Edwards, J
Bartlett, JMS
Citation: J. Edwards et Jms. Bartlett, Induction of apoptosis and inhibition of cellular proliferation as a dual approach to treatment of ovarian cancer, INT J ONCOL, 15(3), 1999, pp. 583-588
Authors:
Wilson, KE
Bartlett, JMS
Miller, EP
Smyth, JF
Mullen, P
Miller, WR
Langdon, SP
Citation: Ke. Wilson et al., Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines, BR J CANC, 80(5-6), 1999, pp. 685-692
Authors:
Simpson, BJB
Bartlett, JMS
Macleod, KG
Rabiasz, G
Miller, EP
Rae, AL
Gordge, P
Leake, RE
Miller, WR
Smyth, J
Langdon, SP
Citation: Bjb. Simpson et al., Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growtheffects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868, BR J CANC, 79(7-8), 1999, pp. 1098-1103
Risultati:
1-16
|